These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. "Just Another Statistic". Machtay M; Glatstein E Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105 [TBL] [Abstract][Full Text] [Related]
6. Pathological quality assurance in gastro-intestinal cancer. van Krieken JH; Nagtegaal ID Eur J Surg Oncol; 2005 Aug; 31(6):675-80. PubMed ID: 15908166 [TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
8. [Infrastructure of cancer clinical trial cooperative groups in western countries]. Fukuda H Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009 [TBL] [Abstract][Full Text] [Related]
9. Beware the Medical-Industrial Complex. Stevens CW; Glatstein E Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005 [TBL] [Abstract][Full Text] [Related]
10. Amended reports in surgical pathology and implications for diagnostic error detection and avoidance: a College of American Pathologists Q-probes study of 1,667,547 accessioned cases in 359 laboratories. Nakhleh RE; Zarbo RJ Arch Pathol Lab Med; 1998 Apr; 122(4):303-9. PubMed ID: 9648896 [TBL] [Abstract][Full Text] [Related]
11. Surgeons: A Future Role in Clinical Trials? Rusch VW Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050 [TBL] [Abstract][Full Text] [Related]
12. Quality assurance in a cooperative group. Wolter JM Cancer Treat Rep; 1985 Oct; 69(10):1189-93. PubMed ID: 4042097 [TBL] [Abstract][Full Text] [Related]
14. Detecting and preventing the occurrence of errors in the practices of laboratory medicine and anatomic pathology: 15 years' experience with the College of American Pathologists' Q-PROBES and Q-TRACKS programs. Novis DA Clin Lab Med; 2004 Dec; 24(4):965-78. PubMed ID: 15555751 [TBL] [Abstract][Full Text] [Related]
15. Agreement and error rates using blinded review to evaluate surgical pathology of biopsy material. Renshaw AA; Cartagena N; Granter SR; Gould EW Am J Clin Pathol; 2003 Jun; 119(6):797-800. PubMed ID: 12817425 [TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites. Zon R; Meropol NJ; Catalano RB; Schilsky RL J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967 [TBL] [Abstract][Full Text] [Related]
18. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
19. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
20. Error rates in Australian chemical pathology laboratories. Khoury M; Burnett L; Mackay MA Med J Aust; 1996 Aug; 165(3):128-30. PubMed ID: 8709873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]